ADDvise Group AB (publ) (ADDV-A.ST)
SEK 11.2
(1.36%)
SEK 11.2
(1.36%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 121.2 Million SEK | 18.2% |
| 2022 | 102.53 Million SEK | 54.09% |
| 2021 | 66.54 Million SEK | 99.1% |
| 2020 | 33.42 Million SEK | -10.28% |
| 2019 | 37.25 Million SEK | 4.14% |
| 2018 | 35.77 Million SEK | 32.56% |
| 2017 | 26.98 Million SEK | 32.99% |
| 2016 | 20.29 Million SEK | 34.41% |
| 2015 | 15.09 Million SEK | 3.34% |
| 2014 | 14.6 Million SEK | 27.47% |
| 2013 | 11.46 Million SEK | 18.97% |
| 2012 | 9.63 Million SEK | 221.1% |
| 2011 | 3 Million SEK | 15.79% |
| 2010 | 2.59 Million SEK | 0.0% |
| 2008 | 869 Thousand SEK | 164.13% |
| 2007 | 329 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 138 Million SEK | 13.86% |
| 2024 Q3 | 129.4 Million SEK | -2.93% |
| 2024 Q2 | 133.3 Million SEK | -3.41% |
| 2023 Q2 | 101.9 Million SEK | 11.24% |
| 2023 Q1 | 91.6 Million SEK | -10.66% |
| 2023 Q3 | 95.7 Million SEK | -6.08% |
| 2023 FY | 121.2 Million SEK | 18.2% |
| 2023 Q4 | 121.2 Million SEK | 26.65% |
| 2022 Q4 | 102.53 Million SEK | -10.33% |
| 2022 FY | 102.53 Million SEK | 54.09% |
| 2022 Q1 | 81.63 Million SEK | 22.68% |
| 2022 Q2 | 96.52 Million SEK | 18.24% |
| 2022 Q3 | 114.34 Million SEK | 18.46% |
| 2021 Q3 | 61.22 Million SEK | 41.83% |
| 2021 Q4 | 66.54 Million SEK | 8.69% |
| 2021 Q1 | 35.69 Million SEK | 6.81% |
| 2021 Q2 | 43.16 Million SEK | 20.92% |
| 2021 FY | 66.54 Million SEK | 99.1% |
| 2020 Q2 | 42.76 Million SEK | 6.88% |
| 2020 Q4 | 33.42 Million SEK | -13.86% |
| 2020 Q3 | 38.79 Million SEK | -9.28% |
| 2020 Q1 | 40.01 Million SEK | 7.42% |
| 2020 FY | 33.42 Million SEK | -10.28% |
| 2019 FY | 37.25 Million SEK | 4.14% |
| 2019 Q4 | 37.25 Million SEK | -20.81% |
| 2019 Q2 | 44.89 Million SEK | 23.31% |
| 2019 Q1 | 36.4 Million SEK | 1.78% |
| 2019 Q3 | 47.04 Million SEK | 4.78% |
| 2018 FY | 35.77 Million SEK | 32.56% |
| 2018 Q4 | 35.77 Million SEK | -6.02% |
| 2018 Q3 | 38.06 Million SEK | 10.36% |
| 2018 Q2 | 34.49 Million SEK | 16.35% |
| 2018 Q1 | 29.64 Million SEK | 9.85% |
| 2017 Q4 | 26.98 Million SEK | -0.24% |
| 2017 Q3 | 27.05 Million SEK | 3.19% |
| 2017 Q2 | 26.21 Million SEK | 2.48% |
| 2017 Q1 | 25.58 Million SEK | 26.07% |
| 2017 FY | 26.98 Million SEK | 32.99% |
| 2016 Q4 | 20.29 Million SEK | 1.43% |
| 2016 Q3 | 20 Million SEK | -5.15% |
| 2016 Q2 | 21.09 Million SEK | 6.68% |
| 2016 Q1 | 19.77 Million SEK | 30.96% |
| 2016 FY | 20.29 Million SEK | 34.41% |
| 2015 Q1 | 14.66 Million SEK | 0.4% |
| 2015 Q2 | 17.06 Million SEK | 16.33% |
| 2015 Q4 | 15.09 Million SEK | -2.56% |
| 2015 Q3 | 15.49 Million SEK | -9.2% |
| 2015 FY | 15.09 Million SEK | 3.34% |
| 2014 FY | 14.6 Million SEK | 27.47% |
| 2014 Q4 | 14.6 Million SEK | 8.02% |
| 2014 Q3 | 13.52 Million SEK | 1.71% |
| 2014 Q2 | 13.29 Million SEK | 7.92% |
| 2014 Q1 | 12.31 Million SEK | 7.5% |
| 2013 Q3 | 12.56 Million SEK | 20.35% |
| 2013 Q4 | 11.46 Million SEK | -8.77% |
| 2013 FY | 11.46 Million SEK | 18.97% |
| 2013 Q1 | 9.56 Million SEK | -0.71% |
| 2013 Q2 | 10.43 Million SEK | 9.12% |
| 2012 Q3 | 10.07 Million SEK | -5.92% |
| 2012 FY | 9.63 Million SEK | 221.1% |
| 2012 Q1 | 7.71 Million SEK | 157.23% |
| 2012 Q4 | 9.63 Million SEK | -4.4% |
| 2012 Q2 | 10.71 Million SEK | 38.78% |
| 2011 Q4 | 3 Million SEK | -14.92% |
| 2011 FY | 3 Million SEK | 15.79% |
| 2011 Q2 | 2.83 Million SEK | 0.11% |
| 2011 Q1 | 2.83 Million SEK | 9.26% |
| 2011 Q3 | 3.52 Million SEK | 24.42% |
| 2010 Q2 | 823 Thousand SEK | 4.57% |
| 2010 FY | 2.59 Million SEK | 0.0% |
| 2010 Q1 | 787 Thousand SEK | 0.0% |
| 2010 Q4 | 2.59 Million SEK | 226.73% |
| 2010 Q3 | 793 Thousand SEK | -3.65% |
| 2009 Q1 | 869 Thousand SEK | 72.76% |
| 2009 Q2 | 860 Thousand SEK | -1.04% |
| 2008 FY | 869 Thousand SEK | 164.13% |
| 2008 Q4 | 503 Thousand SEK | 0.0% |
| 2008 Q1 | 329 Thousand SEK | 0.0% |
| 2007 FY | 329 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -1672.189% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 0.0% |
| Arcoma AB | 28.02 Million SEK | -332.44% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | -308.824% |
| BICO Group AB (publ) | 493.1 Million SEK | 75.421% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | -94.231% |
| CellaVision AB (publ) | 126.03 Million SEK | 3.839% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -1882.011% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -6743.896% |
| C-Rad AB (publ) | 64.09 Million SEK | -89.08% |
| Duearity AB (publ) | 4.15 Million SEK | -2814.162% |
| Dignitana AB (publ) | 7.41 Million SEK | -1534.966% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -3175.676% |
| Getinge AB (publ) | 6.41 Billion SEK | 98.111% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 7299.839% |
| Iconovo AB (publ) | -4.86 Million SEK | 2592.801% |
| Integrum AB (publ) | 22.36 Million SEK | -441.992% |
| Luxbright AB (publ) | 8000.00 SEK | -1514900.0% |
| Mentice AB (publ) | 14.1 Million SEK | -759.331% |
| OssDsign AB (publ) | 4.3 Million SEK | -2715.985% |
| Paxman AB (publ) | 19.99 Million SEK | -506.03% |
| Promimic AB (publ) | 330 Thousand SEK | -36627.273% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -1562.095% |
| SciBase Holding AB (publ) | 11.91 Million SEK | -916.864% |
| ScandiDos AB (publ) | 22.69 Million SEK | -434.156% |
| Sectra AB (publ) | 36.59 Million SEK | -231.238% |
| Sedana Medical AB (publ) | 42.97 Million SEK | -182.024% |
| Senzime AB (publ) | 20.34 Million SEK | -495.87% |
| SpectraCure AB (publ) | 1.00 SEK | -12119999900.0% |
| Stille AB | 66.55 Million SEK | -82.11% |
| Vitrolife AB (publ) | 413 Million SEK | 70.654% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 14.409% |